Necessity of redefinition and revision of mouse unit for tetrodotoxin: Relationship between lethal time and mouse unit of tetrodotoxin in mouse bioassay.

Toxicon

Laboratory of Food Microbiology and Toxicology, College of Agriculture, Ibaraki University, 3-21-1 Chuo, Ami, Inashiki, Ibaraki, 300-0393, Japan; Division of Biomedical Food Research, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-9501, Japan. Electron

Published: October 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: An assay that utilizes the relationship between the amount of toxin administered and the lethal time of mice is called a mouse bioassay (MBA) and has been used as an assay for marine neurotoxins such as paralytic shellfish poison toxins and pufferfish toxins. The MBA for tetrodotoxin (TTX), which is possessed by pufferfish, has been used for many years in Japan. In the Japanese reference method, equivalent to the official method, the toxicity of TTX is expressed in mouse units (M.U.), and 1 M.U. is defined as the amount of the toxins required to kill a 20 g mouse in 30 min and is stated as 0.22 μg of TTX. The regulation limit in food is also expressed in M.U. in Japan.

Objectives: In the previous studies, we have questioned the definition of 1 M.U. of TTX in the currently used Japanese reference method. In this study, we investigated the dose-lethal time relationship of TTX in mice.

Methods: Followed by the Japanese reference method, various doses of TTX were inoculated intraperitoneally into mice (n = 3/each dose) and the time from the end of the injection to the last gasp of breath was measured.

Results: The dose-lethal time relationship curve obtained in this study showed quite similar curves described in the reference method, but lethal time was always shorter than the time in the reference method. Also, the amount of 1 M.U. of TTX could not be determined based on the definition because most of the mice died earlier than 30 min after injection or survived.

Discussion: Based on the dose-lethal time relationship curve obtained in this study, 1 M.U. might be 0.1727 μg of TTX, which was about 22 % smaller than 0.22 μg. Furthermore, based on the definition, it was impossible to determine the amount of TTX for 1 M.U. The author asserts that the definition of M.U. and the amount of TTX for 1 M.U. should be reviewed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.toxicon.2025.108474DOI Listing

Publication Analysis

Top Keywords

reference method
20
lethal time
12
japanese reference
12
dose-lethal time
12
time relationship
12
ttx
10
mouse unit
8
unit tetrodotoxin
8
time
8
mouse bioassay
8

Similar Publications

Background: Interstitial lung disease (ILD) is a significant cause of morbidity and mortality in systemic sclerosis (SSc), particularly among Black patients. Pulmonary function tests (PFTs) are critical to screen for and monitor SSc-ILD. We examined whether race-specific and race-neutral PFT reference equations impact classification of restrictive lung disease (RLD) severity in Black and White patients with SSc.

View Article and Find Full Text PDF

Objective: To evaluate the accuracy of the automated oscillometric upper-arm cuff blood pressure (BP) monitor Microlife BP3KV1-5X (BP B6 Connect) for home use in a general population according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Universal Standard (ISO 81060-2:2018) and its amendments (1:2020 and 2:2024).

Methods: Participants were recruited to fulfill the age, sex, BP, and arm distribution criteria of the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018) and its amendments (1:2020 and 2:2024) in a general population using the same arm sequential measurement method. A single wide-range cuff of the test device was used for arm circumference 22-42 cm.

View Article and Find Full Text PDF

Purpose: To evaluate the feasibility of abbreviated liver magnetic resonance imaging (AMRI) with a second-shot arterial phase (SSAP) image for the viability of treated hepatocellular carcinoma (HCC) after non-radiation locoregional therapy (LRT).

Methods: We retrospectively enrolled patients with non-radiation LRT for HCC who underwent the modified gadoxetic acid-enhanced liver MRI protocol, which includes routine dynamic and SSAP imaging after the first and second injection of gadoxetic acid, respectively (6 mL and 4 mL, respectively), and an available reference standard for tumor viability in the treated HCC between March 2021 and February 2022. Two radiologists independently reviewed the full-protocol MRI (FP-MRI) and AMRI with SSAP.

View Article and Find Full Text PDF

Background: According to the Council of International Organizations and Medical Sciences (CIOMS) 2016, post-trial access (PTA) refers to the ethical imperative that requires the sponsor, researchers, and relevant public health authority, "to make available as soon as possible any intervention or product developed, and knowledge generated, for the population or community in which the research is carried out." Law, policy, and practical guidance for PTA has so far been vague but has recently attracted and increased attention in the context of benefit sharing of scientific research results with low- and middle-income countries (LMICs).Although the number of clinical trials conducted in the Sub Saharan (SSA) countries has increased in the past two decades, plans and practices for PTA are underreported.

View Article and Find Full Text PDF

Severe emphysema impairs lung function and quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD). Despite optimized medical treatment and rehabilitation, some patients require lung volume reduction interventions (endoscopic or surgical). This study evaluates one-year outcomes of patients managed at the Emphysema Clinic of CHU Liège.

View Article and Find Full Text PDF